Here's Why You Should Buy Edward Lifesciences (EW) Stock Now

Edwards Lifesciences Corporation (EW) is gaining from its commitment to advance its leadership position in surgical structural heart therapies. The SAPIEN 3 Ultra RESILIA platform also continues its strong uptake in the United States.Elevated expenses and foreign exchange headwinds are a concern for EW’s business.In the past year, this Zacks Rank #2 (Buy) stock has gained 13.4% compared with 11.2% rise of the industry and 30.8% growth of the S&P 500 composite.The renowned global medical device company has a ...